Cargando…
PMU109 IMPACT of the COVID-19 Pandemic on Patients with Immune-Mediated Inflammatory Diseases Taking a Biologic Therapy
Autores principales: | Halioua, B., Zetlaoui, J., Astruc, A., Testa, D., Bombezin--Domino, A., Radoszycki, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834879/ http://dx.doi.org/10.1016/j.jval.2020.08.1321 |
Ejemplares similares
-
PMU85 IMPACT of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe
por: Halioua, B., et al.
Publicado: (2020) -
PMU63 Post-Lockdown Impact of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in the United States
por: Halioua, B., et al.
Publicado: (2021) -
Impact post-déconfinement de la pandémie de COVID-19 sur les patients chroniques en Europe
por: Astruc, A., et al.
Publicado: (2021) -
POSA363 Lasting Impacts of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe
por: Halioua, B, et al.
Publicado: (2022) -
Impact post-déconfinement de la pandémie de COVID-19 sur les patients chroniques en France
por: Astruc, A., et al.
Publicado: (2021)